Impact of Testosterone Solution 2% on Ejaculatory Dysfunction in Hypogonadal Men.

Area of Science:

• Endocrinology
• Men's Health
• Sexual Medicine

Background:

• Hypogonadism, characterized by low testosterone levels, is associated with sexual dysfunction, including ejaculatory issues.
• Erectile dysfunction is common in hypogonadal men, impacting overall sexual health.

Purpose of the Study:

• To assess the efficacy of a 2% testosterone solution in improving ejaculatory function in hypogonadal men.
• To evaluate the impact of testosterone therapy on bother associated with ejaculatory dysfunction.

Main Methods:

• A randomized, placebo-controlled trial involving 715 hypogonadal men (total testosterone < 300 ng/dL).
• Participants received either 2% testosterone solution or placebo for 12 weeks.
• Ejaculatory function was assessed using the Men's Sexual Health Questionnaire, Ejaculatory Dysfunction, Short Form (MSHQ-EjD-SF).

Main Results:

• Testosterone therapy led to a statistically significant improvement in ejaculatory function scores compared to placebo (P < .001).
• No significant difference was observed between groups regarding the "bother" item of the MSHQ-EjD-SF.
• Adverse events were generally mild and comparable between the testosterone and placebo groups, with few discontinuations.

Conclusions:

• Testosterone solution 2% therapy offers a significant benefit for ejaculatory function in hypogonadal men.
• While functional improvement is noted, the impact on patient-reported bother requires further investigation.
• Testosterone therapy demonstrates a favorable safety profile in this cohort.